Table 4.
Clinical outcomes of COVID-19 between non-aspirin and aspirin users before COVID-19 index date.
| Variables | Non-Aspirin N = 20 |
Aspirin before COVID-19 Index Date N = 15 |
p-Value |
|---|---|---|---|
| Composite endpoint 1, n (%) | 0.043 * | ||
| No | 12 (60.0) | 3 (20.0) | |
| Yes | 8 (40.0) | 12 (80.0) | |
| Composite endpoint 2, n (%) | 0.016 * | ||
| No | 17 (85.0) | 6 (40.0) | |
| Yes | 3 (15.0) | 9 (60.0) | |
| Conventional oxygen therapy | 0.727 * | ||
| No | 13 (65.0) | 8 (53.3) | |
| Yes | 7 (35.0) | 7 (46.7) | |
| Intensive care unit | 0.141 † | ||
| No | 19 (95.0) | 11 (73.3) | |
| Yes | 1 (5.0) | 4 (26.7) | |
| Mechanical ventilation | 0.141 † | ||
| No | 19 (95.0) | 11 (73.3) | |
| Yes | 1 (5.0) | 4 (26.7) | |
| Death | 0.027 † | ||
| No | 19 (95.0) | 9 (60.0) | |
| Yes | 1 (5.0) | 6 (40.0) |
* Pearson’s chi-square test; † Fisher’s exact test; Composite endpoint 1: conventional oxygen therapy, intensive care unit, mechanical ventilation, or death; Composite endpoint 2: intensive care unit, mechanical ventilation, or death.